Medical oncologists’ dance with international guidelines and national reimbursement: insights from a survey in Türkiye
Expert Review of Pharmacoeconomics & Outcomes Research · 2025
DOI: 10.1080/14737167.2025.2462238 ↗Kurz gefasst
Leitlinie in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2025. Verfasst von Ozgur Tanriverdi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Mugla Sıtkı Koçman University Faculty of Medicine, Mugla, Türkiye. Hauptthemen laut MEDLINE: Oncologists, Practice Guidelines as Topic, Practice Patterns, Physicians', Reimbursement Mechanisms. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: This study explores Turkish medical oncologists' perceptions of integrating international treatment guidelines with national reimbursement policies, considering local legal, economic, and healthcare constraints. RESEARCH DESIGN AND METHODS: A cross-sectional online survey was conducted from March 24-31, 2024, targeting all 1,096 active oncologists registered with the Turkish Medical Oncology Association, as these specialists are exclusively authorized to prescribe anticancer drugs under national regulations. The survey included 25 questions on demographics, perceptions of guidelines, and integration preferences. Statistical analyses, including chi-square tests and logistic regression, identified factors influencing guideline preferences. RESULTS: Among 337 respondents (31%), 94% found international guidelines essential, but 62% noted a lack of clear real-world algorithms. Significant predictors for preferring national guidelines included working in public institutions (OR: 3.90, p < 0.001), concerns about pharmaceutical industry influence (OR: 4.38, p = 0.017), legal challenges (OR: 5.89, p < 0.001), and variability among clinical research centers (OR: 2.95, p = 0.019). Despite these challenges, 57% favored national guidelines for their compatibility with local healthcare policies. CONCLUSIONS: The findings highlight the need for hybrid models that merge the evidence-based rigor of international frameworks with local healthcare priorities. Such models can enhance equitable and effective cancer care in Türkiye by addressing both global standards and national realities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Mugla Sıtkı Koçman University Faculty of Medicine, Mugla, Türkiye.
- Department of Medical Oncology, Pamukkale University Faculty of Medicine, Denizli, Türkiye.
- Medical Oncology Clinic, Health Sciences University Van Education and Research Hospital, Van, Türkiye.
- Department of Medical Oncology, Ege University Faculty of Medicine, İzmir, Türkiye.
- Department of Medical Oncology, Katip Celebi University Atatürk Education and Research Hospital, Izmir, Türkiye.
- Department of Medical Oncology, Adnan Menderes University Faculty of Medicine, Aydin, Türkiye.
ORCID-Profile: Ozgur Tanriverdi
Zitieren
APA
Tanriverdi, O., Ozdemir, M., Hafizoglu, E., Guclu, T., Almurodova, E., Kitapli, S., Bosna, I. C., Dubektas-Canbek, T., Oflazoglu, U., Alkan, A., & Barutca, S. (2025). Medical oncologists’ dance with international guidelines and national reimbursement: insights from a survey in Türkiye. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2462238
Vancouver
Tanriverdi O, Ozdemir M, Hafizoglu E, Guclu T, Almurodova E, Kitapli S, et al. Medical oncologists’ dance with international guidelines and national reimbursement: insights from a survey in Türkiye. Expert Review of Pharmacoeconomics & Outcomes Research. 2025. doi:10.1080/14737167.2025.2462238
BibTeX
@article{Tanriverdi2025,
author = {Tanriverdi, Ozgur and Ozdemir, Melek and Hafizoglu, Emre and Guclu, Taliha and Almurodova, Elvina and Kitapli, Sait and Bosna, Islam Cagri and Dubektas-Canbek, Tugba and Oflazoglu, Utku and Alkan, Ali and Barutca, Sabri},
title = {Medical oncologists’ dance with international guidelines and national reimbursement: insights from a survey in Türkiye},
journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
year = {2025},
doi = {10.1080/14737167.2025.2462238}
}
EUVIMED